This white paper represents a compilation of industry best practices for designing, implementing and leveraging randomization and trial supply management (RTSM) software in clinical trials.
Understand how Metrics provide the foundation for business intelligence for clinical trials, measuring success or failure.
Read how new technological solutions are enabling humanistic patient reported outcomes (PROs) that enhance Real-World Evidence (RWE) and support better informed healthcare decisions.
Learn more about how you can control diabetes, and give patients the opportunity to take back their life and enjoy what makes them happy.
Immuno-oncology is a unique approach to cancer treatment that leverages the body’s immune system to help fight cancer. In recent years, immune checkpoint inhibitors have changed the landscape of immunotherapy, and emerging therapies such as chimeric antigen receptor T-cells (CAR-T), dendritic cell vaccines and bi-specific T-cell engager (BiTE) antibodies are pushing the envelope even further.
Read how utilizing electronic data capture systems ─ including eCOA ─ and training site raters, subjects and caregivers are important tools to ensure high quality data capture in rare disease research.
How applying EDC savings in that way would mean replacing paper could have not only business benefits, but public health implications as well.
As the global reach of clinical trials has increased, and with the deadline for EU compliance quickly arriving, many in pharma are finding themselves in a dilemma.
This article reviews current trends in Real-World Data (RWD) collection and how clinical trial sponsors can generate significant returns on investment by utilizing innovative technologies to overcome the perceived challenges that hinder some patient-centric initiatives.
This article reviews three strategies that will help sponsors and CROs cut the time and cost of their trials while improving respiratory data quality.
|
|
|
|
|
|
|
|
|